Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Novel Method Effective for Screening Multiple Cancer Types
Finding cancer at the earliest stage possible, before it can spread, can significantly boost a patient’s chances of survival. However, it isn’t always easy as some cancers don’t produce any symptoms until it is too late for treatment to be successful. A new...
Ohio Lab Company Settles Inpatient Double Billing Claims for $142.7K
...
Register
Thermo Fisher Draws First Blood in Lawsuit Over Defective COVID-19 PCR Tests
...
Register
Drug Test Lab Pays $4.8 Million for Charging Medicaid above MFN Rate
...
Register
Jury Socks Natera with $44.9 Million False Advertising Verdict
...
Register
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
...
Register
A Model Attestation Statement for Laboratories
To guard against reimbursement denials due to improper signatures, labs can give MACs an attestation statement from the physician or NPP.
Medicare Reimbursement Briefing: How Will Recent Changes Affect You?
...
Register
Balwani Loses Bid to Bar Incriminating Evidence from Fraud Trial
Even before the trial began, things got off to a rocky start for the ex-Theranos CEO, who faces charges of fraud and wire fraud.
NCI Program Expands Access to Key Diagnostic for Childhood Cancers
A new initiative launched by the National Institutes of Health’s National Cancer Institute (NCI) on March 21 will bring a state-of-the art diagnostic option to children, adolescents, and young adults who have recently been diagnosed with central nervous system...
